Embecta EMBC
NASDAQ EMBC
$6.71 -0.15 (-2.19%)
At close: Oct 23, 2026 · 4:00 PM EDT

Embecta (EMBC) Net Income towards Common Stockholders (2020 - 2026)

Updated

Embecta's Net Income towards Common Stockholders was $21.1 million in fiscal Q3 2026 (quarter ended Jun 30, 2026), down 53.6% from $45.5 million a year earlier.

Analysis

Embecta (EMBC) Net Income towards Common Stockholders (2020 - 2026) Analysis & Trends

On a trailing twelve-month basis, Embecta's Net Income towards Common Stockholders was $87.5 million through Jun 30, 2026, up 4.7% year-over-year; for FY2025 (ended Sep 30, 2025), it came in at $95.4 million, up 21.8% from FY2024.

  • Net Income towards Common Stockholders shows a five-year compound annual growth rate of -25.9% (FY2020 to FY2025).
  • In earlier fiscal years, Net Income towards Common Stockholders was $78.3 million in FY2024 (+11.2%), $70.4 million in FY2023 (-68.5%), $223.6 million in FY2022 (-46.1%) and $414.8 million in FY2021 (-3.0%).
  • Quarterly Net Income towards Common Stockholders has moved between -$17.2 million (fiscal Q4 2022) and $98.8 million (fiscal Q1 2022) over five years.
  • Compared with a year earlier, Net Income towards Common Stockholders was higher in three of the last five quarters, with growth averaging 72.3%.
  • The best year-over-year quarter for Net Income towards Common Stockholders over five years was fiscal Q3 2025 (growth of 209.5%); the worst was fiscal Q2 2023 (a decline of 82.4%).
  • Per Business Quant data, EMBC's Net Income towards Common Stockholders in the three fiscal quarters before Q3 2026 was -$4.1 million (Q2 2026), $44.1 million (Q1 2026) and $26.4 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Thermo Fisher Scientific 249.17 Bn 228.32 Bn 4.88 Bn 1.74 Bn
2 Abbott Laboratories 179.42 Bn 150.51 Bn 7.27 Bn 928.00 Mn
3 Danaher 161.98 Bn 145.80 Bn 3.61 Bn 870.00 Mn
4 Intuitive Surgical 156.76 Bn 137.18 Bn 2.08 Bn 522.80 Mn
5 Medtronic 122.13 Bn 88.00 Bn 6.34 Bn 1.47 Bn
6 Stryker 117.84 Bn 103.96 Bn 4.50 Bn 1.28 Bn
7 Boston Scientific 66.19 Bn 61.20 Bn 3.85 Bn 907.00 Mn
8 Becton Dickinson 54.16 Bn 51.31 Bn 2.32 Bn 377.00 Mn
9 Edwards Lifesciences 51.35 Bn 35.47 Bn 1.35 Bn 241.90 Mn
10 Embecta 380.19 Mn -446.21 Mn 153.30 Mn 21.10 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 21.10 Mn
Mar 31, 2026 -4.10 Mn
Dec 31, 2025 44.10 Mn
Sep 30, 2025 26.40 Mn
Jun 30, 2025 45.50 Mn
Mar 31, 2025 23.50 Mn
Sep 30, 2024 14.60 Mn
Jun 30, 2024 14.70 Mn
Mar 31, 2024 28.90 Mn
Dec 31, 2023 20.10 Mn
Sep 30, 2023 6.00 Mn
Jun 30, 2023 15.20 Mn
Mar 31, 2023 14.00 Mn
Dec 31, 2022 35.20 Mn
Sep 30, 2022 -17.20 Mn
Jun 30, 2022 62.40 Mn
Mar 31, 2022 79.60 Mn
Dec 31, 2021 98.80 Mn
Sep 30, 2021 96.90 Mn
Jun 30, 2021 104.70 Mn
API Access

Embecta Net Income towards Common Stockholders API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-income-towards-common-stockholders&ticker=EMBC&period=max&api_key=YOUR_API_KEY